Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teneligliptin for Left Ventricular Diastolic Dysfunction in Type 2 Diabetes
NCT02449330Phase 4Unknown
- Sponsor
- National Cerebral and Cardiovascular Center
- Start
- Jun 2015
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of teneligliptin in type 2 diabetes mellitus (T2DM), sponsored by National Cerebral and Cardiovascular Center. Status: unknown.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02449330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02449330.